Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury

  • Authors:
    • Xiaoyue Zhang
    • Wenchao Hong
    • Na Li
    • Xiaohui Gong
    • Cheng Cai
  • View Affiliations / Copyright

    Affiliations: Department of Neonatology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 733
    |
    Published online on: October 26, 2022
       https://doi.org/10.3892/etm.2022.11669
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To explore the optimal stage of initiating continuous renal replacement therapy (CRRT) in the treatment of neonatal acute kidney injury (AKI), a total of 25 AKI neonates treated with CRRT were hospitalized at the Department of Neonatology of Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University (Shanghai, China) from November 2016 to June 2021. According to the renal function, the AKI neonates prior to CRRT were divided into two groups as follows: AKI stage 0‑1 and AKI stage 2‑3. The changes noted in specific indicators including renal function, electrolyte concentration, and acid‑base balance index were analyzed at 0, 12, 24 and 48 h, and at the end of the CRRT treatment. Among the 25 neonates with AKI, serum potassium, urea nitrogen and creatinine levels were significantly decreased following 12 h of CRRT treatment and reached the normal range following 24 h of CRRT treatment with a significant increase in the volume of urine. The serum creatinine levels of the neonates in the AKI stage 0‑1 group were significantly decreased following 24 h of CRRT treatment and urine output was significantly increased. At 24 h and following CRRT treatment, the levels of serum creatinine of AKI stage 2‑3 neonates were higher than those of AKI stage 0‑1 neonates (F=3.013, 5.005; P<0.05), and at all time‑points, the urine output of AKI stage 0‑1 was higher than that of AKI stage 2‑3 (F=13.785, 4.008, 0.965; P<0.05). A total of four cases of thrombocytopenia, two cases of obstruction, and two cases of hypotension were noted in the course of CRRT treatment (the occurrence rate was 8/25). Therefore, it was concluded that CRRT could be an effective measure for the treatment of AKI neonates. Thus, ideally CRRT treatment of AKI neonates should be initiated in cases characterized as AKI stages 0‑1.
View Figures

Figure 1

Figure 2

View References

1 

Kavanaugh KJ, Jetton JG and Kent AL: Neonatal acute kidney injury: Understanding of the impact on the smallest patients. Crit Care Clin. 37:349–363. 2021.PubMed/NCBI View Article : Google Scholar

2 

Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, Chishti AS, Woroniecki R, Mammen C, Swanson JR, et al: Incidence and outcomes of neonatal acute kidney injury (AWAKEN): A multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 1:184–194. 2017.PubMed/NCBI View Article : Google Scholar

3 

Gallo D, de Bijl-Marcus KA, Alderliesten T, Lilien M and Groenendaal F: Early acute kidney injury in preterm and term neonates: Incidence, outcome, and associated clinical features. Neonatology. 118:174–179. 2021.PubMed/NCBI View Article : Google Scholar

4 

Diane Mok TY, Tseng MH, Chiang MC, Lin JL, Chu SM, Hsu JF and Lien R: Renal replacement therapy in the neonatal intensive care unit. Pediatr Neonatol. 59:474–480. 2018.PubMed/NCBI View Article : Google Scholar

5 

Erkol Tuncer GH, Ekim M, Okulu E, Atasay B and Kendirli T: Continuous renal replacement therapy in critically ill children: single-center experience. Turk J Med Sci. 51:188–194. 2021.PubMed/NCBI View Article : Google Scholar

6 

Khwaja A: KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 120:c179–c184. 2012.PubMed/NCBI View Article : Google Scholar

7 

SooHoo MM, Patel SS, Jaggers J, Faubel S and Gist KM: Acute kidney injury defined by fluid corrected creatinine in neonates after the norwood procedure. World J Pediatr Congenit Heart Surg. 9:513–521. 2018.PubMed/NCBI View Article : Google Scholar

8 

Yoon BR, Leem AY, Park MS, Kim YS and Chung KS: Optimal timing of initiating continuous renal replacement therapy in septic shock patients with acute kidney injury. Sci Rep. 9(11981)2019.PubMed/NCBI View Article : Google Scholar

9 

Suzuki J, Ohnuma T, Sanayama H, Ito K, Fujiwara T, Yamada H, Lefor AK and Sanui M: The optimal timing of continuous renal replacement therapy according to the modified RIFLE classification in critically ill patients with acute kidney injury: A retrospective observational study. Renal Replacement Therapy. 3(30)2017.

10 

Roman-Filip C, Catană MG, Bereanu A, Lăzăroae A, Gligor F and Sava M: Therapeutic plasma exchange and double filtration plasmapheresis in severe neuroimmune disorders. Acta Clin Croat. 58:621–626. 2019.PubMed/NCBI View Article : Google Scholar

11 

Uber AM and Sutherland SM: Acute kidney injury in hospitalized children: Consequences and outcomes. Pediatr Nephrol. 35:213–220. 2020.PubMed/NCBI View Article : Google Scholar

12 

Mian AN, Askenazi DJ and Mhanna MJ: Therapeutic options for neonatal acute kidney injury (AKI). Curr Treat Opt Pediatrics. 2:1–13. 2016.

13 

Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi DJ and Kent AL: Neonatal Acute kidney injury. Pediatrics. 136:e463–e473. 2015.PubMed/NCBI View Article : Google Scholar

14 

Perico N, Askenazi D, Cortinovis M and Remuzzi G: Maternal and environmental risk factors for neonatal AKI and its long-term consequences. Nat Rev Nephrol. 14:688–703. 2018.PubMed/NCBI View Article : Google Scholar

15 

Safina AI, Daminova MA and Abdullina GA: Acute kidney injury in neonatal intensive care: Medicines involved. Int J Risk Saf Med. 27 (Suppl 1):S9–S10. 2015.PubMed/NCBI View Article : Google Scholar

16 

Askenazi DJ: AWAKEN-Ing a new frontier in neonatal nephrology. Front Pediatr. 8(21)2020.PubMed/NCBI View Article : Google Scholar

17 

Goldstein SL: Pediatric continuous renal replacement therapy for ‘40 years of continuous renal replacement therapy’. Contrib Nephrol. 194:146–154. 2018.PubMed/NCBI View Article : Google Scholar

18 

Cho AY, Yoon HJ, Lee KY and Sun IO: Clinical characteristics of sepsis-induced acute kidney injury in patients undergoing continuous renal replacement therapy. Ren Fail. 40:403–409. 2018.PubMed/NCBI View Article : Google Scholar

19 

Continuous renal replacement therapies, international conference. San Diego, California, November 8-10, 1995. Abstracts. Blood Purif. 13:385–402. 1995.PubMed/NCBI View Article : Google Scholar

20 

Ricci Z and Goldstein SL: Pediatric continuous renal replacement therapy. Contrib Nephrol. 187:121–30. 2016.PubMed/NCBI View Article : Google Scholar

21 

Ronco C, Ricci Z and Goldstein SL: (R)evolution in the management of acute kidney injury in newborns. Am J Kidney Dis. 66:206–211. 2015.PubMed/NCBI View Article : Google Scholar

22 

Kes P and Basić Jukić N: Acute kidney injury in the intensive care unit. Bosn J Basic Med Sci 10 Suppl. 1 (Suppl 1):S8–S12. 2010.PubMed/NCBI View Article : Google Scholar

23 

Gorga SM, Sahay RD, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Zappitelli M, Gist KM, Gien J, Basu RK, et al: Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: A multicenter retrospective cohort study. Pediatr Nephrol. 35:871–882. 2020.PubMed/NCBI View Article : Google Scholar

24 

Ronco C, Garzotto F, Brendolan A, Zanella M, Bellettato M, Vedovato S, Chiarenza F, Ricci Z and Goldstein SL: Continuous renal replacement therapy in neonates and small infants: Development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet. 383:1807–1813. 2014.PubMed/NCBI View Article : Google Scholar

25 

Noh ES, Kim HH, Kim HS, Han YS, Yang M, Ahn SY, Sung SI, Chang YS and Park WS: Continuous renal replacement therapy in preterm infants. Yonsei Med J. 60:984–991. 2019.PubMed/NCBI View Article : Google Scholar

26 

Garzotto F, Vidal E, Ricci Z, Paglialonga F, Giordano M, Laforgia N, Peruzzi L, Bellettato M, Murer L and Ronco C: Continuous kidney replacement therapy in critically ill neonates and infants: A retrospective analysis of clinical results with a dedicated device. Pediatr Nephrol. 35:1699–1705. 2020.PubMed/NCBI View Article : Google Scholar

27 

Hu Y, Peng XM and Xiao ZH: Application of continuous renal replacement therapy in the treatment of neonates with inherited metabolic diseases. Zhongguo Dang Dai Er Ke Za Zhi. 23:488–493. 2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).

28 

Pedersen O, Jepsen SB and Toft P: Continuous renal replacement therapy for critically ill infants and children. Dan Med J. 59(A4385)2012.PubMed/NCBI

29 

Lee ST and Cho H: Fluid overload and outcomes in neonates receiving continuous renal replacement therapy. Pediatr Nephrol. 31:2145–2152. 2016.PubMed/NCBI View Article : Google Scholar

30 

Kellum JA and Ronco C: The 17th acute disease quality initiative international consensus conference: Introducing precision renal replacement therapy. Blood Purif. 42:221–223. 2016.PubMed/NCBI View Article : Google Scholar

31 

Riley AA, Watson M, Smith C, Guffey D, Minard CG, Currier H and Akcan Arikan A: Pediatric continuous renal replacement therapy: Have practice changes changed outcomes? A large single-center ten-year retrospective evaluation. BMC Nephrol. 19(268)2018.PubMed/NCBI View Article : Google Scholar

32 

Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJ, Bunchman TE and Goldstein SL: Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis. 41:984–989. 2003.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang X, Hong W, Li N, Gong X and Cai C: Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Exp Ther Med 24: 733, 2022.
APA
Zhang, X., Hong, W., Li, N., Gong, X., & Cai, C. (2022). Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Experimental and Therapeutic Medicine, 24, 733. https://doi.org/10.3892/etm.2022.11669
MLA
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24.6 (2022): 733.
Chicago
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24, no. 6 (2022): 733. https://doi.org/10.3892/etm.2022.11669
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Hong W, Li N, Gong X and Cai C: Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Exp Ther Med 24: 733, 2022.
APA
Zhang, X., Hong, W., Li, N., Gong, X., & Cai, C. (2022). Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Experimental and Therapeutic Medicine, 24, 733. https://doi.org/10.3892/etm.2022.11669
MLA
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24.6 (2022): 733.
Chicago
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24, no. 6 (2022): 733. https://doi.org/10.3892/etm.2022.11669
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team